Olanzapine-induced QTc prolongation in a patient with Wolff-Parkinson-White syndrome.
Su
Kuan-Pin
KP
Lane
Hsien-Yuan
HY
Chuang
Chiao-Lin
CL
Chen
Kun-Po
KP
Shen
Winston W
WW
D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001569:Benzodiazepines / Q000008:administration & dosage / Q000009:adverse effects*; D001714:Bipolar Disorder / Q000150:complications* / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008133:Long QT Syndrome / Q000139:chemically induced*; D008875:Middle Aged; D000077152:Olanzapine; D014927:Wolff-Parkinson-White Syndrome / Q000150:complications*
D014150:Antipsychotic Agents; D001569:Benzodiazepines; D000077152:Olanzapine